Evidence for a critical period for postnatal elevation of brain tyrosine hydroxylase activity resulting from reserpine administration during embryonic development.
D000818:Animals; D001921:Brain / Q000187:drug effects / Q000201:enzymology*; D001923:Brain Chemistry / Q000187:drug effects*; D002250:Carbon Radioisotopes; D002384:Catalysis; D002642:Chick Embryo; D002645:Chickens; D004296:Dopa Decarboxylase / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D009929:Organ Size; D012110:Reserpine / Q000008:administration & dosage / Q000494:pharmacology*; D013997:Time Factors; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism*
D002250:Carbon Radioisotopes; D012110:Reserpine; D014446:Tyrosine 3-Monooxygenase; D004296:Dopa Decarboxylase